TROVIS PHARMACEUTICALS, LLC
Patent Owner
Stats
- 2 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Oct 08, 2013 most recent publication
Details
- 2 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 466 Total Citation Count
- Mar 31, 2004 Earliest Filing
- 21 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
8222228 Substituted aryl piperidinylalkynyladenosines as A2AR agonistsExpiredDec 29, 10Jul 17, 12[A61K, A01N]
2011/0082,157 Piperidinylamino-Thieno [2,3-D] Pyrimidine CompoundsAbandonedJun 08, 10Apr 07, 11[A61K, C07D, A61P]
2010/0280,050 Piperidinylamino-Thieno[2,3-D] Pyrimidine Compounds for Treating FibrosisAbandonedSep 04, 08Nov 04, 10[A61K, A61P]
2010/0113,485 Piperidinylamino-thieno[2,3-D] Pyrimidine CompoundsAbandonedOct 30, 09May 06, 10[A61K, C07D, A61P]
7612078 Piperidinylamino-thieno[2,3-D] pyrimidine compoundsExpiredMar 08, 05Nov 03, 09[A61K, C07D, A61P]
7589076 Substituted aryl piperidinylalkynyladenosines as A2AR agonistsExpiredMay 17, 07Sep 15, 09[A61K, A01N]
2009/0181,920 INTRATHECAL TREATMENT OF NEUROPATHIC PAIN WITH A2AR AGONISTSAbandonedJan 09, 09Jul 16, 09[A61K, A61P]
7470697 Pyrrolo[3,2-D] pyrimidines that are selective antagonists of A.sub.2B adenosine receptorsExpiredAug 31, 07Dec 30, 08[C07D]
2008/0262,001 AGONISTS OF A2A ADENOSINE RECEPTORS FOR TREATING RECURRENT TUMOR GROWTH IN THE LIVER FOLLOWING RESECTIONAbandonedApr 14, 08Oct 23, 08[A61K, A61P]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
